New Data Shows Alzheimer's Drug Can Benefit Some Patients

Dr. Madhav Thambisetty of Johns Hopkins School of Medicine joins Morning Joe to discus the results of a clinical trial of an experimental Alzheimer’s drug that suggest that the treatment slowed cognitive decline somewhat for people in the early stages of the disease.